What it is
Informed consent is a conversation, not just a signature. A licensed clinician explains a proposed treatment in plain language, and you have the chance to ask questions, think it over, and say yes or no. A form may document that conversation, but the form is not the conversation.
With stem cell products, informed consent matters even more because the regulatory picture is mixed. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. Stem cell, mesenchymal stem cell (MSC), bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses.
The FDA has warned the public about unapproved stem cell clinics and products. Reported risk categories include infection, immune reaction, tumor formation at the injection site, and permanent injury from unapproved products injected into the eye or spine. Honest consent discussions name risks like these rather than offering vague reassurance.
How it’s traditionally been approached
Informed consent is a long-standing principle in medicine and research. Clinicians have traditionally been expected to disclose the nature of a procedure, its risks, its possible benefits, and reasonable alternatives, and to respect a patient's right to decline.
For established treatments, including approved blood-forming stem cell transplants, consent is typically part of a structured process within a hospital or specialty program. Care teams often review the plan across more than one visit, and patients may bring a family member or ask for a second opinion.
For experimental care, the traditional route has been a registered clinical trial, where independent review and oversight apply. People can learn about registered trials through ClinicalTrials.gov, a public registry. Some people also explore options with their own physician first, since a doctor who knows their history may help them weigh what is realistic.
How the right provider may help
The right provider may help by slowing the process down and making the decision clear. A visit generally starts with an evaluation of your history and current concerns. Only a licensed clinician can decide what is appropriate for you after that evaluation, and a good one is comfortable saying when a product is not a fit.
A thorough consent discussion may cover a checklist like this: the exact product and its FDA status; the specific risks; a realistic chance of benefit; alternatives, including doing nothing; the total cost disclosed in writing; and your right to walk away at any time. Ask where the product comes from, who prepares it, and what happens if something goes wrong. Take your time, and consider asking for the information in writing to review at home.
Red flags worth noticing: guarantees of results; words like 'cure' or 'regrow'; refusal to name the product or its FDA status; pressure to decide quickly; and discouraging a second opinion. Treatment abroad, often called medical tourism, is materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to address from a distance. A vetted domestic provider is generally a safer first step. If you have a concern after treatment, you can report it through the FDA's MedWatch safety reporting program and to your state medical board.
The whole-person view
Body, mind and stress affect each other. Hoping for relief from pain or a long illness can make a confident sales pitch feel very persuasive, and stress can make it harder to weigh risks calmly. Noticing how your body and emotions respond during a consultation can be useful information.
Body-based support, such as the approaches offered by Somatic Experiences practitioners, may help some people feel more settled when facing health decisions. Talk therapy through Therapists.plus may help you sort through fear, hope and pressure. Neither replaces medical guidance, and both are options to consider alongside it.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- This page is educational only and is not medical, legal or financial advice, and it is not an informed consent form.
- Licensed professionals should guide care for serious conditions, and only a licensed clinician can decide what is appropriate for you after an evaluation.
- Most stem cell products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses, so ask any provider directly about FDA status.
- For emergencies call 911; in a crisis call or text the 988 Lifeline.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
What is informed consent for stem cell therapy?
Informed consent for stem cell therapy is a discussion in which a licensed clinician explains the exact product, its FDA status, risks, realistic chance of benefit and alternatives before you agree. You should be free to ask questions and to decline. A signed form documents the talk but does not replace it.
What should be included in a stem cell therapy informed consent?
A good consent discussion generally covers the exact product and its FDA status, specific risks, a realistic chance of benefit, alternatives including doing nothing, total cost disclosure, and your right to walk away. This is a checklist to guide your questions, not a legal template. Ask for anything unclear to be explained in plain words.
Is stem cell therapy FDA-approved?
Only some uses are. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are clearly FDA-approved. Stem cell, bone marrow aspirate, adipose-derived, umbilical cord and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses.
What risks should a clinic tell me about?
Reported risk categories include infection, immune reaction, tumor formation at the injection site, and permanent injury from unapproved products injected into the eye or spine. A provider should describe risks specific to the product and the procedure, not just offer general reassurance. Ask what would happen if a complication occurred.
What are red flags during a stem cell consultation?
Red flags include guarantees of results, 'cure' or 'regrow' language, refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. Any one of these is a good reason to pause. Getting a second opinion from another licensed clinician is always reasonable.
How do I report a problem after stem cell treatment, or find a legitimate trial?
You can report a suspected problem through the FDA's MedWatch safety reporting program and to your state medical board. To explore legitimate experimental care, search ClinicalTrials.gov, a public registry of registered clinical trials, and discuss options with your own physician. Treatment abroad carries higher risk, so a vetted domestic provider is a safer first step.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.